loadpatents
name:-0.027092218399048
name:-0.02154803276062
name:-0.0055639743804932
Fokt; Izabela Patent Filings

Fokt; Izabela

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fokt; Izabela.The latest application filed is for "esters of 2-deoxy-monosaccharides with anti proliferative activity".

Company Profile
5.25.25
  • Fokt; Izabela - Houston TX
  • Fokt; Izabela - Spring TX
  • Fokt; Izabela - The Woodlands TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Esters Of 2-deoxy-monosaccharides With Anti Proliferative Activity
App 20220023326 - Priebe; Waldemar ;   et al.
2022-01-27
Esters of 2-deoxy-monosaccharides with anti proliferative activity
Grant 11,026,960 - Priebe , et al. June 8, 2
2021-06-08
Caffeic acid derivatives and uses thereof
Grant 10,703,721 - Priebe , et al.
2020-07-07
Esters Of 2-deoxy-monosaccharides With Anti Proliferative Activity
App 20190224225 - PRIEBE; Waldemar ;   et al.
2019-07-25
DNA binding agents with a minor groove binding tail
Grant 10,358,439 - Priebe , et al. July 23, 2
2019-07-23
Caffeic Acid Derivatives And Uses Thereof
App 20190177276 - PRIEBE; Waldemar ;   et al.
2019-06-13
Esters of 2-deoxy-monosacharides with anti proliferative activity
Grant 10,201,554 - Priebe , et al. Feb
2019-02-12
Dna Binding Agents With A Minor Groove Binding Tail
App 20180251454 - PRIEBE; Waldemar ;   et al.
2018-09-06
Esters Of 2-deoxy-monosacharides With Anti Proliferative Activity
App 20160184336 - Priebe; Waldemar ;   et al.
2016-06-30
Inhibitors of glycolysis useful in the treatment of brain tumors
Grant 9,149,489 - Priebe , et al. October 6, 2
2015-10-06
Compounds for treatment of cell proliferative diseases
Grant 9,096,499 - Priebe , et al. August 4, 2
2015-08-04
Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)
Grant 9,000,179 - Priebe , et al. April 7, 2
2015-04-07
Orally Bioavailable Caffeic Acid Related Anticancer Drugs
App 20150094343 - PRIEBE; Waldemar ;   et al.
2015-04-02
Acetates of 2-deoxy monosaccharides with anticancer activity
Grant 8,927,506 - Priebe , et al. January 6, 2
2015-01-06
Compounds For Treatment Of Cell Proliferative Diseases
App 20140329901 - PRIEBE; Waldemar ;   et al.
2014-11-06
Novel Inhibitors Of Proliferation And Activation Of Signal Transducer And Activator Of Transcription (stats)
App 20140228414 - PRIEBE; Waldemar ;   et al.
2014-08-14
Orally bioavailable caffeic acid related anticancer drugs
Grant 8,779,151 - Priebe , et al. July 15, 2
2014-07-15
Compounds for treatment of cell proliferative diseases
Grant 8,648,102 - Priebe , et al. February 11, 2
2014-02-11
Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)
Grant 8,637,675 - Priebe , et al. January 28, 2
2014-01-28
Interferon Therapies In Combination With Blockade Of Stat3 Activation
App 20130129675 - Priebe; Waldemar ;   et al.
2013-05-23
Iodo-hexose compounds useful to treat cancer
Grant 8,299,033 - Priebe , et al. October 30, 2
2012-10-30
Thermally-targeted delivery of medicaments including doxorubicin
Grant 8,252,740 - Raucher , et al. August 28, 2
2012-08-28
Compounds For Treatment Of Cell Proliferative Diseases
App 20120214850 - Priebe; Waldemar ;   et al.
2012-08-23
Novel Inhibitors Of Proliferation And Activation Of Signal Transducer And Activators Of Transcription (stats)
App 20120149738 - Priebe; Waldemar ;   et al.
2012-06-14
Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)
Grant 8,143,412 - Priebe , et al. March 27, 2
2012-03-27
Compounds for treatment of cell proliferative diseases
Grant 8,119,827 - Priebe , et al. February 21, 2
2012-02-21
Novel Acetates of 2-Deoxy Monosaccharides with Anticancer Activity
App 20110160151 - Priebe; Waldemar ;   et al.
2011-06-30
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
Grant 7,928,062 - Kirken , et al. April 19, 2
2011-04-19
Novel Inhibitors of Proliferation and Activation of Signal Transducer and Activator of Transcription (STATS)
App 20110053992 - Priebe; Waldemar ;   et al.
2011-03-03
Compounds For Treatment Of Cell Proliferative Diseases
App 20110021805 - Priebe; Waldemar ;   et al.
2011-01-27
Inhibitors of Glycolysis Useful In the Treatment of Brain Tumors
App 20110003758 - Priebe; Waldemar ;   et al.
2011-01-06
Compounds for treatment of cell proliferative diseases
Grant 7,745,468 - Priebe , et al. June 29, 2
2010-06-29
Iodo-Hexose Compounds Useful to Treat Cancer
App 20100152121 - Priebe; Waldemar ;   et al.
2010-06-17
Small Molecule Inhibitors for Immune Modulation
App 20100144802 - Heimberger; Amy B. ;   et al.
2010-06-10
Hexose Compounds to Treat Cancer
App 20100130434 - Priebe; Waldemar ;   et al.
2010-05-27
Thermally-targeted Delivery Of Medicaments Including Doxorubicin
App 20100022466 - Raucher; Drazen ;   et al.
2010-01-28
Methods For Selectively Inhibiting Janus Tyrosine Kinase 3 (jak3)
App 20080167220 - KIRKEN; Robert A. ;   et al.
2008-07-10
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
Grant 7,365,096 - Kirken , et al. April 29, 2
2008-04-29
Orally Bioavailable Caffeic Acid Related Anticancer Drugs
App 20070232668 - Priebe; Waldemar ;   et al.
2007-10-04
Compounds for treatment of cell proliferative diseases
App 20050277680 - Priebe, Waldemar ;   et al.
2005-12-15
Methods for selectively inhibiting janus tyrosine kinase 3 (JAK3)
App 20050203177 - Kirken, Robert A. ;   et al.
2005-09-15
Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents
Grant 6,680,300 - Priebe , et al. January 20, 2
2004-01-20
Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents
App 20030023052 - Priebe, Waldemar ;   et al.
2003-01-30
Bis-anthracyclines with high activity against doxorubicin resistant tumors
Grant 5,874,412 - Priebe , et al. February 23, 1
1999-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed